{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:37:59Z","timestamp":1784039879920,"version":"3.55.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG-FOR2886"],"award-info":[{"award-number":["DFG-FOR2886"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1181"],"award-info":[{"award-number":["CRC1181"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Checkpoints for Resolution of Inflammation"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"BMBF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>miRNAs are small non-coding RNAs that control gene expression. Specific intra- and extracellular miRNA signatures have been identified in various diseases. Whether certain miRNA signatures are associated with psoriasis (PsO) and PsA is currently unknown. We aimed to search for circulating miRNA signatures associated with PsO and PsA patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Expression of miRNAs was analysed by reverse transcription quantitative real-time PCR (RT-qPCR) in the serum of PsA, PsO patients and healthy controls. Demographic and disease-specific characteristics and imaging data from hand MRI were recorded. In the discovery phase, 192 miRNA assays were analysed in 48 samples (PsA, PsO, controls: each N\u2009=\u200916). For validation, 17 selected miRNAs were measured in the total population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 141 patients and controls were analysed (51 PsA, 40 PsO, 50 controls). In the discovery phase 51 miRNAs in PsO and 64 miRNAs in PsA were down- or upregulated compared with controls, with 33 miRNAs being changed in both (adj. P\u2009&amp;lt;\u20090.05). The 17 top candidates from discovery were assessed in the validation phase, 9 of them discriminated PsA and PsO from controls [area under the curve (AUC) \u22650.70, all P\u2009&amp;lt;\u20090.05]. Four miRNAs (miR-19b-3p, miR-21-5p, miR-92a-3p and let-7b-5p) were significantly differently regulated between PsO and PsA. A combination of these miRNAs increased the AUC to 0.92 in multivariate regression model to discriminate PsO and PsA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>miRNA signatures in PsA and PsO patients differ from controls. Nine miRNAs were differentially regulated in PsA and PsO patients, five of them previously reported to be involved in bone and cartilage metabolism, indicating an intimate association of psoriatic inflammation and bone\/cartilage changes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead059","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T13:01:20Z","timestamp":1675429280000},"page":"3448-3458","source":"Crossref","is-referenced-by-count":12,"title":["Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4758-6785","authenticated-orcid":false,"given":"Judith","family":"Haschka","sequence":"first","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology, I Medical Department at Hanusch Hospital of OEGK , Vienna, Austria"},{"name":"Karl Landsteiner Institute for Gastroenterology and Rheumatology, Rheuma-Zentrum Wien-Oberlaa , Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-7820","authenticated-orcid":false,"given":"David","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bayat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Messner","sequence":"additional","affiliation":[{"name":"Karl Landsteiner Institute for Gastroenterology and Rheumatology, Rheuma-Zentrum Wien-Oberlaa , Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kampylafka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Fagni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Skalicky","sequence":"additional","affiliation":[{"name":"TAmiRNA GmbH , Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hackl","sequence":"additional","affiliation":[{"name":"TAmiRNA GmbH , Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Resch","sequence":"additional","affiliation":[{"name":"Karl Landsteiner Institute for Gastroenterology and Rheumatology, Rheuma-Zentrum Wien-Oberlaa , Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology, I Medical Department at Hanusch Hospital of OEGK , Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Kleyer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Cavallaro","sequence":"additional","affiliation":[{"name":"Department of Radiology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sticherling","sequence":"additional","affiliation":[{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Department of Dermatology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goerg","family":"Schett","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kocijan","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology, I Medical Department at Hanusch Hospital of OEGK , Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Rech","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"2023100322120341500_kead059-B1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","article-title":"Psoriatic arthritis from a mechanistic perspective","volume":"18","author":"Schett","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2023100322120341500_kead059-B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3899\/jrheum.090218","article-title":"Psoriatic arthritis sine psoriasis","volume":"83","author":"Olivieri","year":"2009","journal-title":"J Rheumatol Suppl"},{"key":"2023100322120341500_kead059-B3","first-page":"ii14","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2023100322120341500_kead059-B4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med"},{"key":"2023100322120341500_kead059-B5","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/S0140-6736(18)30949-8","article-title":"Clinical management of psoriatic arthritis","volume":"391","author":"Van den Bosch","year":"2018","journal-title":"Lancet"},{"key":"2023100322120341500_kead059-B6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023100322120341500_kead059-B7","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","article-title":"Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis","volume":"75","author":"Faustini","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023100322120341500_kead059-B8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13075-020-2111-8","article-title":"A set of serum markers detecting systemic inflammation in psoriatic skin, entheseal, and joint disease in the absence of C-reactive protein and its link to clinical disease manifestations","volume":"22","author":"Sokolova","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2023100322120341500_kead059-B9","doi-asserted-by":"crossref","first-page":"115787","DOI":"10.1016\/j.bone.2020.115787","article-title":"Circulating miRNAs in bone health and disease","volume":"145","author":"Grillari","year":"2021","journal-title":"Bone"},{"key":"2023100322120341500_kead059-B10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mce.2015.10.015","article-title":"Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases?","volume":"432","author":"Hackl","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"2023100322120341500_kead059-B11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/ijms17030349","article-title":"MicroRNAs in osteoclastogenesis and function: potential therapeutic targets for osteoporosis","volume":"17","author":"Ji","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2023100322120341500_kead059-B12","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3899\/jrheum.090352","article-title":"The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands","volume":"36","author":"Ostergaard","year":"2009","journal-title":"J Rheumatol"},{"key":"2023100322120341500_kead059-B13","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1210\/jc.2016-2365","article-title":"Circulating microRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures","volume":"101","author":"Kocijan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2023100322120341500_kead059-B14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","article-title":"Assessing sample and miRNA profile quality in serum and plasma or other biofluids","volume":"59","author":"Blondal","year":"2013","journal-title":"Methods"},{"key":"2023100322120341500_kead059-B15","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res"},{"key":"2023100322120341500_kead059-B16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2015.05.027","article-title":"Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation","volume":"79","author":"Weilner","year":"2015","journal-title":"Bone"},{"key":"2023100322120341500_kead059-B17","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1210\/jc.2017-02585","article-title":"Altered microRNA profile in osteoporosis caused by impaired WNT signaling","volume":"103","author":"Makitie","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023100322120341500_kead059-B18","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/jbmr.4097","article-title":"Unique, gender-dependent serum microRNA profile in PLS3 gene-related osteoporosis","volume":"35","author":"Makitie","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2023100322120341500_kead059-B19","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2023100322120341500_kead059-B20","doi-asserted-by":"crossref","first-page":"102391","DOI":"10.1016\/j.autrev.2019.102391","article-title":"MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact","volume":"18","author":"Evangelatos","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2023100322120341500_kead059-B21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/hmg\/ddy008","article-title":"Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients","volume":"27","author":"Perez-Sanchez","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2023100322120341500_kead059-B22","doi-asserted-by":"crossref","first-page":"7305380","DOI":"10.1155\/2018\/7305380","article-title":"MicroRNA expression profiling in psoriatic arthritis","volume":"2018","author":"Pelosi","year":"2018","journal-title":"Biomed Res Int"},{"key":"2023100322120341500_kead059-B23","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023100322120341500_kead059-B24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/jcm8010110","article-title":"MiR-146a-5p expression in peripheral CD14(+) monocytes from patients with psoriatic arthritis induces osteoclast activation, bone resorption, and correlates with clinical response","volume":"8","author":"Lin","year":"2019","journal-title":"J Clin Med"},{"key":"2023100322120341500_kead059-B25","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar2493","article-title":"Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Pauley","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"2023100322120341500_kead059-B26","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3899\/jrheum.190602","article-title":"Serum MicroRNA signature as a diagnostic and therapeutic marker in patients with psoriatic arthritis","volume":"47","author":"Wade","year":"2020","journal-title":"J Rheumatol"},{"key":"2023100322120341500_kead059-B27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13148-017-0428-1","article-title":"Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes","volume":"9","author":"Ntoumou","year":"2017","journal-title":"Clin Epigenetics"},{"key":"2023100322120341500_kead059-B28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123909","article-title":"A complex relationship between visfatin and resistin and microRNA: an in vitro study on human chondrocyte cultures","volume":"19","author":"Cheleschi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2023100322120341500_kead059-B29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2021.08.001","article-title":"Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study","volume":"239","author":"Cheleschi","year":"2022","journal-title":"Transl Res"},{"key":"2023100322120341500_kead059-B30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcp.2019.02.031","article-title":"Micro-RNAs in inflammatory arthritis: from physiopathology to diagnosis, prognosis and therapeutic opportunities","volume":"165","author":"Najm","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"2023100322120341500_kead059-B31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4236\/ojra.2019.93010","article-title":"Genetic factors and psoriatic arthritis","volume":"09","author":"Greco","year":"2019","journal-title":"Open J Rheumatol Autoimmune Dis"},{"key":"2023100322120341500_kead059-B32","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/s41598-018-22844-2","article-title":"Bone-related circulating microRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their association to bone microstructure and histomorphometry","volume":"8","author":"Feichtinger","year":"2018","journal-title":"Sci Rep"},{"key":"2023100322120341500_kead059-B33","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?","volume":"2","author":"Sonkoly","year":"2007","journal-title":"PLoS One"},{"key":"2023100322120341500_kead059-B34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1365-2133.2011.10497.x","article-title":"microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris","volume":"165","author":"Ichihara","year":"2011","journal-title":"Br J Dermatol"},{"key":"2023100322120341500_kead059-B35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0625.2012.01462.x","article-title":"MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis","volume":"21","author":"Meisgen","year":"2012","journal-title":"Exp Dermatol"},{"key":"2023100322120341500_kead059-B36","doi-asserted-by":"crossref","first-page":"225re1","DOI":"10.1126\/scitranslmed.3008089","article-title":"Targeting miR-21 to treat psoriasis","volume":"6","author":"Guinea-Viniegra","year":"2014","journal-title":"Sci Transl Med"},{"key":"2023100322120341500_kead059-B37","first-page":"113","article-title":"Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis","volume":"35","author":"Ciancio","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2023100322120341500_kead059-B38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1753425919842932","article-title":"Serum miR-21 expression correlates with radiographic progression but also low bone mineral density in patients with ankylosing spondylitis: a cross-sectional study","volume":"25","author":"Zou","year":"2019","journal-title":"Innate Immun"},{"key":"2023100322120341500_kead059-B39","doi-asserted-by":"crossref","first-page":"e73443","DOI":"10.1371\/journal.pone.0073443","article-title":"First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS)","volume":"8","author":"Lucherini","year":"2013","journal-title":"PLoS One"},{"key":"2023100322120341500_kead059-B40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fphar.2019.00367","article-title":"Inhibitory effect of KP-A038 on osteoclastogenesis and inflammatory bone loss is associated with downregulation of blimp1","volume":"10","author":"Ihn","year":"2019","journal-title":"Front Pharmacol"},{"key":"2023100322120341500_kead059-B41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/art.39544","article-title":"Identification of a novel toll-like receptor 7 endogenous ligand in rheumatoid arthritis synovial fluid that can provoke arthritic joint inflammation","volume":"68","author":"Kim","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023100322120341500_kead059-B42","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.16203","article-title":"Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis","volume":"34","author":"Pasquali","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023100322120341500_kead059-B43","doi-asserted-by":"crossref","first-page":"34617","DOI":"10.1038\/srep34617","article-title":"PTEN ameliorates autoimmune arthritis through down-regulating STAT3 activation with reciprocal balance of Th17 and Tregs","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"2023100322120341500_kead059-B44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13075-015-0742-y","article-title":"Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritis","volume":"17","author":"Bluml","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2023100322120341500_kead059-B45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/bjd.12381","article-title":"Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-alpha therapy","volume":"169","author":"Pivarcsi","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead059\/49228446\/kead059.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/10\/3448\/51841465\/kead059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/10\/3448\/51841465\/kead059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T22:13:31Z","timestamp":1696371211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/10\/3448\/7025492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,2,3]]},"published-print":{"date-parts":[[2023,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead059","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,2,3]]}}}